SIEGALL CLAY B bought IMNM
July 23, 2026 · Form 4 insider transaction
SIEGALL CLAY B bought 360,000 shares of Immunome, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
360,000
Price
$0.00
Total value
N/A
InsiderSIEGALL CLAY B
RoleOfficer, Director
CompanyImmunome, Inc. (IMNM)
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateJuly 23, 2026
Filing dateJuly 27, 2026
Shares owned after360,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date.